Comparative efficacy of switching to natalizumab in active multiple sclerosis

OBJECTIVE: To compare treatment efficacy and persistence in patients who switched to natalizumab versus those who switched between glatiramer acetate (GA) and interferon-beta (IFNβ) after an on-treatment relapse on IFNβ or GA using propensity score matched real-world datasets. METHODS: Patients incl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Clin Transl Neurol
Autors principals: Spelman, Timothy, Kalincik, Tomas, Zhang, Annie, Pellegrini, Fabio, Wiendl, Heinz, Kappos, Ludwig, Tsvetkova, Larisa, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek, Grand-Maison, Francois, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Lugaresi, Alessandra, Lechner-Scott, Jeannette, Oreja-Guevara, Celia, Hupperts, Raymond, Petersen, Thor, Barnett, Michael, Trojano, Maria, Butzkueven, Helmut
Format: Artigo
Idioma:Inglês
Publicat: BlackWell Publishing Ltd 2015
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402083/
https://ncbi.nlm.nih.gov/pubmed/25909083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.180
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars